September 13, 2013
Abreos Biosciences is bringing a solution to the marketplace to identify counterfeit drugs in the supply chain down to the patient. With the rising costs of drugs, there is more incentive for criminals to sneak false substances into the marketplace. Just tracking packaging is not sufficient to root out the fake drugs.
Listen to the full interview
Abreos Biosciences’ founder Bradley Messmer discusses how to protect patients from counterfeit medication on The Empowered Patient radio show